Extensive genetic diversity of severe fever with thrombocytopenia syndrome virus circulating in Hubei Province, China, 2018-2022

PLoS Negl Trop Dis. 2023 Sep 18;17(9):e0011654. doi: 10.1371/journal.pntd.0011654. eCollection 2023 Sep.

Abstract

Severe fever with thrombocytopenia syndrome virus (SFTSV), an etiological agent causing febrile human disease was identified as an emerging tick-borne bunyavirus. The clinical disease characteristics and case fatality rates of SFTSV may vary across distinct regions and among different variant genotypes. From 2018 to 2022, we surveyed and recruited 202 severe fever with thrombocytopenia syndrome (SFTS) patients in Hubei Province, a high-incidence area of the epidemic, and conducted timely and systematic research on the disease characteristics, SFTSV diversity, and the correlation between virus genome variation and clinical diseases. Our study identified at least 6 genotypes of SFTSV prevalent in Hubei Province based on the analysis of the S, M, and L genome sequences of 88 virus strains. Strikingly, the dominant genotype of SFTSV was found to change during the years, indicating a dynamic shift in viral genetic diversity in the region. Phylogenetic analysis revealed the genetic exchange of Hubei SFTSV strains was relatively frequent, including 3 reassortment strains and 8 recombination strains. Despite the limited sample size, SFTSV C1 genotype may be associated with higher mortality compared to the other four genotypes, and the serum amyloid A (SAA) level, an inflammatory biomarker, was significantly elevated in these patients. Overall, our data summarize the disease characteristics of SFTSV in Hubei Province, highlight the profound changes in viral genetic diversity, and indicate the need for in-depth monitoring and exploration of the relationship between viral mutations and disease severity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bunyaviridae Infections* / epidemiology
  • China / epidemiology
  • Genetic Variation
  • Humans
  • Phlebovirus* / genetics
  • Phylogeny
  • Severe Fever with Thrombocytopenia Syndrome*

Grants and funding

This study was supported by the National Natural Science Foundation of China (NSFC project No. U20A20396 and No. 81991220308 to W. H.) and the NSFC (No. 82000021 to L.-J. C.), the National Key Research and Development Program of China (2018YFE0204500 to Y.-R. L.), the Young Elite Scientist Sponsorship Program By CAST (YESS20200394 to L.-J. C), and the Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University (No. ZNLH201905 and No. ZNLH202203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript